Trentham D E, Dynesius R A, Rocklin R E, David J R
N Engl J Med. 1978 Aug 17;299(7):327-32. doi: 10.1056/NEJM197808172990703.
We examined patients with rheumatoid arthritis for cellular sansitivity to native human Types I, II and III collagens. Mononuclear cells from 50 patients with rheumatoid arthritis, 21 with other inflammatory arthritides, 20 with osteoarthritis and 20 normal subjects were evaluated for the in vitro production of leukocyte inhibitory factor in response to collagen and a control antigen, streptokinase-streptodornase. By this assay, cells from 37 (74 per cent) and 39 (78 per cent) of the patients with rheumatoid arthritis responded to Types II and III collagens, respectively. In contrast, cells from the 41 patients with other kinds of arthritis and the normal group did not produce this lymphokine to collagens. There was no response to Type I collagen or to denatured alpha chains of these collagens. All four groups responded equivalently to streptokinase-streptodornase. These data demonstrate that most patients with rheumatoid arthritis exhibit cellular sensitivity to Types II and III collagens.
我们检测了类风湿性关节炎患者对天然人I型、II型和III型胶原蛋白的细胞敏感性。评估了50例类风湿性关节炎患者、21例其他炎性关节炎患者、20例骨关节炎患者和20名正常受试者的单核细胞在体外对胶原蛋白和对照抗原链激酶-链道酶产生白细胞抑制因子的情况。通过该检测,分别有37例(74%)和39例(78%)类风湿性关节炎患者的细胞对II型和III型胶原蛋白有反应。相比之下,41例其他类型关节炎患者和正常组的细胞对胶原蛋白未产生这种淋巴因子。对I型胶原蛋白或这些胶原蛋白的变性α链无反应。所有四组对链激酶-链道酶的反应相当。这些数据表明,大多数类风湿性关节炎患者对II型和III型胶原蛋白表现出细胞敏感性。